Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, T-Cell, Peripheral × liposomal doxorubicin × 30 days × Clear all

Sponsor

Conditions

Ovarian Neoplasms 8 Fallopian Tube Neoplasms 5 Breast Neoplasms 4 Triple Negative Breast Neoplasms 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Neoplasms 2 Neoplasm Metastasis 2 Multi-centric Castleman's Disease 2 Vaccinia 1 Sarcoma, Kaposi 1 Sarcoma, Ewing 1 Macular dystrophy, corneal type 1 1 Lymphoproliferative Disorders 1 Lymphadenopathy 1 Low Grade Serous Ovarian Cancer 1 Hodgkin Disease 1 HIV Infections 1 Acquired Immunodeficiency Syndrome 1

Interventions

sodium-iodide symporter 1 selinexor 1 relatlimab 1 fludarabine 1 decitabine and cedazuridine drug combination 1 cemiplimab 1 belinostat 1 X-Rays 1 Specimen Handling 1 Salvage Therapy 1 Photons 1 Nivolumab 1 Magnetic Resonance Spectroscopy 1 Ipilimumab 1 Immunoglobulin G 1 Disulfides 1 Cyclophosphamide 1 CTLA-4 Antigen 1 Biopsy 1 Azacitidine 1 Abatacept 1 ASTX-660 1 10-propargyl-10-deazaaminopterin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡